September 20, 2024

Bioinformatics analysis based on extracted ingredients combined with network pharmacology, molecular docking and molecular dynamics simulation to explore the mechanism of Jinbei oral liquid in the therapy of Idiopathic Pulmonary Fibrosis – ScienceDirect.com

September 18, 2024

Insilico Medicine reports positive Phase IIa results for ISM001-055, a novel first-in-class drug treatment for idiopathic pulmonary fibrosis (IPF) designed using generative AI – EurekAlert

September 16, 2024

Trimetallic-based nanocarriers method shows promise for visualized idiopathic pulmonary fibrosis therapy – Phys.org

September 14, 2024

Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis – ACS Publications

September 12, 2024

Role of telomere dysfunction and immune infiltration in idiopathic pulmonary fibrosis: new insights from bioinformatics analysis – Frontiers